Search Results 661-670 of 16386 for Interindividual

  1. Publications - Ryan M. Giddings Connolly, M.D. - Mayo Clinic

    Hennessy MA, Gatsonis C, Jacene H, Connolly RM, Burnette BL, Stringer-Reasor EM, Romanoff J, Taurone A, O'Sullivan CC, Le-Petross HT, Stearns V, Fowler AM, ...

  2. Immune thrombocytopenia (ITP) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  4. A Study of Defitelio (Defibrotide) for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) - Mayo Clinic

    The purpose of this study is to compare the defibrotide prophylaxis arm vs. standard of care arm for the prevention of aGvHD. Participation eligibility.

  5. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    The purpose of this study is to evaluate DCR-PHXC in patients with primary hyperoxaluria type 1 (PH1) and severe renal impairment, with or without dialysis.

  6. International Hip Dysplasia Registry (IHDR) with Follow-up to Skeletal Maturity - Mayo Clinic

    The purpose of this study is to develop a general prospective registry that includes all elements of the DDH spectrum, from mild dysplasia of a reduced hip, to ...

  7. Neurology - Clinical trials

    It is not yet known whether giving memantine hydrochloride and WBRT with or without hippocampal avoidance works better in reducing neurocognitive decline in ...

  8. ONC Real World Testing at Mayo Clinic for Public Health Reporting via Electronic Laboratory Reporting (ELR)

    Mayo Clinic Lab Registry assigns reportable test results from Mayo Clinic's Department of Lab Medicine and Pathology (DLMP) and produces ELR data to meet ...

  9. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

    The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy ...

  10. A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...